PuraPharm Corporation Limited
PuraPharm Corporation Limited (HKSE: 1498) is trading at HK$0.26, about ₹3 at today's HKD/INR rate, as of 22 Sep 2026, 3:26 AM ET, up 3.24% today. Indian residents can buy PuraPharm from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.25
Today's high
HK$0.26
52 week low
HK$0.23
52 week high
HK$0.46
1498 opened at HK$0.25, closed previously at HK$0.25, and has traded between HK$0.23 and HK$0.46 over the past 52 weeks.
About
PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.
Key statistics
Avg. volume
446.92K
Market cap
HK$136.44M
P/E Ratio
-4.48
Price-to-sales ratio
0.42
Enterprise value
HK$494.83M
Free cash flow yield
-19.73%
Debt-to-equity ratio
2.99
Return on equity
-21.73%
ROIC
-2.99%
Beta
0.20
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
HK$336.11M
Earnings per share
-HK$0.08
Free cash flow
HK$25.69M
Net profit margin
-8.55%
Gross margin
54.59%
EBITDA
HK$6.23M
Revenue growth
-12.03%
Similar securities
This is not an investment recommendation
How to buy PuraPharm from India
Indian residents can buy PuraPharm shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for PuraPharm and place an order
Find PuraPharm by name or by its ticker, 1498, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. PuraPharm trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your PuraPharm position in HKD and INR. PuraPharm pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in PuraPharm from India
Trading and taxes when buying PuraPharm from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NonePuraPharm does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy PuraPharm stock?
Yes. PuraPharm (1498) has been listed on the Hong Kong Stock Exchange since 2015, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one PuraPharm share cost in rupees?
One PuraPharm share is HK$0.26 — about ₹3 at an HKD/INR rate of 12.23 on 26 Sep 2026. Both the PuraPharm price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying PuraPharm from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of PuraPharm?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on PuraPharm shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the PuraPharm price. Paasa issues a capital-gains statement for your return.
Does PuraPharm pay a dividend?
No. PuraPharm does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade PuraPharm from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on PuraPharm shares held from India?
Hong Kong has no estate duty.
Do I have to declare PuraPharm shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your PuraPharm holding, its cost and its closing value.
How do I sell PuraPharm and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.